Contact : 25 rue Jacques Callot - 66000 Perpignan - France
info@antidote-europe.org
Tel : 33 (0)4 68 80 53 32
Lundi et jeudi de 10h30 à 18h / Monday and Thursday from 10h30 to 18h
Home
Learn more
Press
Join us

Our team

Antidote Europe is run by Claude Reiss, our President, Augustine Savy, our secretary and Françoise Reiss, our treasurer.

Initially trained as a physicist, Claude Reiss conducted his post-graduate studies at the University of San Diego, California. On his return to France, he found himself drawn to the subject of biology. This was at the time when the Frenchmen Jacques Monod and François Jacob had just been awarded the Nobel Prize for their research on the genetics of bacteria.

Claude Reiss studied biophysics, before progressing to molecular biology and subsequently, toxicology. His research focused on two main areas of interest:

- protein translation and the folding mechanism: exploring this subject would lead him to put forward several hypotheses as to the possible origins of such neurological diseases as Alzheimer's, Parkinson's, Creutzfeldt-Jakob (the human equivalent of 'mad cow' disease ) and multiple sclerosis.

- the aids virus and its reproductive strategy: here Claude Reiss would develop a novel therapeutic approach to this disease, which would subsequently be patented in the United States. A lack of funding is currently holding back the required preclinical studies.

For more than thirty years, Claude Reiss held the position of research director, at the C.N.R.S. (French National Centre for Scientific Research) and also conducted research at the Jacques Monod Institute. In addition, he taught biology to doctoral students at the University of Lille. He has now retired from his positions in the public sector and is currently conducting his own research, as a personal venture in the private sector.

He played a leading role in organising two European workshops on the subject of cellular and molecular toxicology. The first was held in Sophia Antipolis in 1996, and the second in Paris in 1999. The latter led to the publication of the book: Molecular Responses to Xenobiotics, under the editorial supervision of G. Labbe, H. Parvez, S. Parvez and C. Reiss (Elsevier publishers, 2001).

Augustine Savy, formerly an assistant-director, is currently retired. A founder member of Antidote Europe, she is very active in promoting the aims of the organisation..

Françoise Reiss is emeritus research director at the C.N.R.S. and an internationally recognised figure in the field of bacterial photosynthesis.

Having produced more than 150 published papers, she conclusively demonstrated how the photosynthetic apparatus could convert the energy derived from light into chemical energy, so vital for the cell. She was a pioneer in documenting the actual structures involved in the process - a supreme technical achievement of itself - as well as a decisive breakthrough in understanding photosynthesis.

André Menache works as C.E.O. Born in Belgium, he obtained his degree in veterinary medicine in South Africa in 1980. His scientific opposition to animal experimentation led him to uncover serious methodological shortcomings in human experimentation ('clinical trials'), about which he has published several papers.

He has a particular interest in medical law and was instrumental in amending the Declaration of Helsinki. His proposal to use non-animal methods in scientific research was adopted by the World Medical Association General Assembly in Edinburgh, Scotland, in 2000. His current field of interest is that of regulatory toxicology.

Hélène Sarraseca is Antidote Europe's administrative director and also co-founder. She is responsible for all correspondence with members, administrative duties, and editing the quarterly publication, La Notice d'Antidote.

A graduated in neurosciences, she began a promising career at the C.N.R.S. However, not wishing to conduct any animal experiments, she relinquished her PhD and instead, took up a position as scientific editor in a biotech company and subsequently held various posts within the company, including patent administrator, until the company was bought out by a pharmaceutical concern. She is the author of the book Animaux cobayes et victimes humaines (éditions Dangles, 2006).